An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting
Clinical trial NCT02557035 · COMPLETED
Trial details
- NCT number
- NCT02557035
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-03-01
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.